by Brooke Blazr | Apr 19, 2026 | High Dispatch
Every so often, a cannabis brand enters the market with a level of clarity that is immediately recognizable. Before the product is opened, before the effect is experienced, there is already a sense that the company understands exactly what it wants to communicate. In...
by Brooke Blazr | Apr 18, 2026 | High Dispatch
President Donald Trump used a White House press appearance on Saturday, April 18, to announce a new executive order aimed at accelerating federal research into psychedelic treatments for serious mental illness, with a specific focus on veterans living with PTSD and...
by Brooke Blazr | Apr 18, 2026 | High Dispatch
We understand: a huge part of why people are turning to AI for medical advice is because it’s just so accessible. But more importantly, especially in the field of medical marijuana, obtaining formal medical advice can be very difficult. More than that, there is still...
by Brooke Blazr | Apr 17, 2026 | High Dispatch
4/20 marks the unofficial start of festival season—and this year, Zig-Zag is everywhere. From Denver to Atlanta, Austin to Las Vegas, the heritage rolling paper brand is showing up across the country in a way that reflects the evolution of cannabis culture. Instead...
by Brooke Blazr | Apr 15, 2026 | High Dispatch
Read it carefully and you’ll find something remarkable — not alarm, not moral panic, but a measured, almost bored scientific assessment. Dr. W.W. Stockberger of the Bureau of Plant Industry told the publication there was “no reason to become excited about...
by Brooke Blazr | Apr 14, 2026 | High Dispatch
There’s a specific kind of credibility that only comes from the inside. When cannabis advocates say the Controlled Substances Act is a broken instrument of policy failure, it gets filed under “predictable.” When a former senior DEA official writes...
